Short-Term Hemodynamic Effects of Modern Wheat Products Substitution in Diet with Ancient Wheat Products: A Cross-Over, Randomized Clinical Trial
Open Access
- 3 November 2018
- Vol. 10 (11), 1666
- https://doi.org/10.3390/nu10111666
Abstract
Recent evidence suggests that bioactive compounds isolated from cereals and legumes could exert some metabolic and vascular effects in humans. Due to the recent identification of a non-specific lipid transfer protein (nsLTP2) in wheat with antioxidant and anti-inflammatory activity, we aimed to comparatively test the hemodynamic and metabolic effects of ancient wheat foodstuffs (made of organic KAMUT® khorasan wheat) or modern wheat ones, made of a mixture of organic modern commercial durum (T. durum) varieties and soft wheat (T. aestivum), with different nsLTP2 content. Thus, we carried out a randomized, cross-over clinical trial on 63 non-diabetic healthy volunteers (aged 40–70 years) with systolic blood pressure (SBP) 130–139 mmHg and/or diastolic blood pressure (DBP) 85–90 mmHg (pre-hypertensive/borderline high pressure subjects). Each treatment period lasted four weeks. After ancient wheat foodstuffs intake, subjects experienced a significant improvement in triglycerides (−9.8% vs. baseline and −14.5% versus modern wheat), fasting plasma glucose (−4.3% versus baseline and −31.6% versus modern wheat), diurnal SBP (−3.1% vs. baseline and –30.2% vs. modern wheat) and nocturnal SBP (−3.2% vs. baseline and −36.8% vs. modern wheat), and pulse volume change (+4.2% vs. baseline and +2.3% vs. modern wheat) (p < 0.05 vs. baseline and versus modern wheat foodstuffs intake). Therefore, our findings show that substituting modern wheat products in diet with ancient wheat ones, might exert a mild improvement in 24-h SBP and endothelial reactivity in pre-hypertensive healthy subjects.Keywords
Funding Information
- Seventh Framework Programme (312090)
This publication has 33 references indexed in Scilit:
- Characterization of Khorasan wheat (Kamut) and impact of a replacement diet on cardiovascular risk factors: cross-over dietary intervention studyEuropean Journal of Clinical Nutrition, 2013
- Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressureJournal Of Hypertension, 2013
- Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocityJournal Of Hypertension, 2012
- Central aortic blood pressure, augmentation index, and reflected wave transit time: reproducibility and repeatability of data obtained by oscillometryVascular Health and Risk Management, 2011
- Profiles of phenolic compounds in modern and old common wheat varieties determined by liquid chromatography coupled with time-of-flight mass spectrometryJournal of Chromatography A, 2011
- Comparison of ABTS/DPPH assays to measure antioxidant capacity in popular antioxidant-rich US foodsJournal of Food Composition and Analysis, 2011
- Role of cereal type and processing in whole grain in vivo protection from oxidative stressFrontiers in Bioscience-Landmark, 2011
- Validity and repeatability of the Vicorder apparatus: a comparison with the SphygmoCor deviceHypertension Research, 2009
- Pulse Wave Analysis and Pulse Wave Velocity A Review of Blood Pressure Interpretation 100 Years After KorotkovCirculation Journal, 2006
- The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP AssayAnalytical Biochemistry, 1996